Pharmacokinetic Optimisation in the Treatment of Gastro-Oesophageal Reflux Disease
- 1 November 1996
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 31 (5) , 386-406
- https://doi.org/10.2165/00003088-199631050-00005
Abstract
Gastro-oesophageal reflux disease (GORD) is a very common disorder of upper gastro-intestinal motility, differing widely in severity and prognosis. Medical therapy of GORD has involved antacids,...Keywords
This publication has 97 references indexed in Scilit:
- Effect of lansoprazole on intragastric pHDigestive Diseases and Sciences, 1992
- CisaprideDrugs, 1988
- Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in manEuropean Journal of Clinical Pharmacology, 1988
- Pharmakodynamik und Pharmakokinetik des neuen H2-Rezeptorantagonisten Roxatidinacetat nach multiplen Dosen bei gesunden MännernDrugs, 1988
- Pharmakokinetik von Roxatidinacetat bei chronischer NiereninsuffizienzDrugs, 1988
- Nizatidine, an H2-Receptor Antagonist: Disposition and Safety in the ElderlyThe Journal of Clinical Pharmacology, 1987
- Kinetics of the Inhibition of Food-Stimulated Secretion by Ranitidine in DogsEuropean Surgical Research, 1985
- DomperidoneDrugs, 1982
- Evaluation of elevation of the head of the bed, bethanechol, and antacid foam tablets on gastroesophageal refluxDigestive Diseases and Sciences, 1981
- Pharmacokinetics of Cimetidine after Single Doses and during Continuous TreatmentClinical Pharmacokinetics, 1981